Women with anemia of chronic disease with ID had a reduced ferritin prior to treatment (mean ferritin 11 ± 4.6 μg/l and mean transferrin saturation 17.4 ± 12.5%) but had no signs of iron deficient erythropoiesis shown by normal levels of HRC (mean of HRC 1 ± 0.7%), RDW (mean of RDW 14.0 ± 1.5%), MRC (mean of MRC 2.2 ± 2.9%), and CHr (mean of CHr 30.6 ± 2.6 pg) at the start of the therapy (Figures 3 and 4). Here, TF is linked to anemia.